The open index of psychedelic research

Prospective Multicentre Observational Registry of Peri-procedural Anaesthesia, Sedation and Related Medication Exposure in Patients With Brugada Syndrome

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.

Aicher HD, Dornbierer J, Caflisch L +6

Perioperative intravenous lidocaine plus esketamine and patient-reported recovery after functional endoscopic sinus surgery.

Zheng X, Xie S, Li Q +4

Micro-phenomenology of immersion and perceived presences under DMT.

Sanders JW, Millière R, Demšar E +4

Dose-effect analysis of 6-APB ("Benzofury") on fear memory, motor behavior, and reward.

Whitelock KM, Van Alstyne KR, Conaboy LJ +2

Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study

Zarrabi AJ, Mletzko T, Grant G +13

Treatment-resistant Depression in the Post-ketamine Era: Unmet Needs beyond Rapid Response.

Serretti A

Effects of Esketamine Combined With Pericapsular Nerve Group Block on Quality of Recovery, Analgesic Outcomes, and Hemodynamics in Elderly Patients Undergoing Total Hip Arthroplasty.

Wu X, Zhao D, Hu C +1

Association between prenatal methamphetamine exposure and intracranial haemorrhage in neonates and infants: nationwide cohort study.

Lin CH, Lin C, Lin WS +4

Interrogating roles for VTA dopamine neurons in locomotion and ultrasonic vocalizations elicited by different classes of rewarding drugs.

Lawson KA, Mahler SV

Psychedelic therapy at the end of life: unexplored alternative to assisted suicide in the UK.

Zinchenko R

The ANCHOR Framework for Psychedelic Accompaniment

Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology.

Gould TD, Mathew SJ, Fava M +1

Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study.

Meyer TD, Vale LN, Ibrahim M +3

Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants

Mason NL, Haijen-Bongers EC, Kuypers KP +4

Is the reduction in suicidal ideation and deliberate self-harm during intranasal esketamine treatment independent of antidepressant response? A secondary, longitudinal analysis of a real-world TRD cohort with and without comorbid borderline personality disorder

Longitudinal dream-content shift and void-like dissociative phenomenology around outpatient ketamine infusions in chronic low back pain: a case report.

Torii K, Nishitani R

Process-dependent N-nitroso-ketamine formation during ketamine active pharmaceutical ingredient manufacturing: part I impact of process design, solvent selection, and activated carbon.

Zou G, Wang H, Lupitskyy R +5

An integrated living dataset of psilocybin and psilocin publications, preprints, and trial records

Germann, Christopher B.

Esketamine-propofol anesthesia for elective cardioversion in atrial fibrillation.

Mion G, Bouatrous W, Samama CM

Systems-based psychiatry: insights from psychedelic research on mechanisms of healing.

Shannon S, Weil A

Shared Neurobiological and Computational Mechanisms of Psychedelic, Contemplative, and Fasting-Induced Mystical Experience

Jinich-Diamant A

MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments

Brinzei OV